tiprankstipranks
Trending News
More News >
Mineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
PremiumThe FlyMineralys Therapeutics price target lowered to $48 from $52 at Guggenheim
26d ago
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 5/14/2025, According to Top Analysts
26d ago
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
Premium
Ratings
Strong Financial Position and Promising Clinical Results Support Buy Rating for Mineralys Therapeutics
27d ago
Mineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
PremiumPre-EarningsMineralys Therapeutics, Inc. (MLYS) Q1 Earnings Cheat Sheet
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
Premium
The Fly
Mineralys Therapeutics’ lorundrostat shows efficacy in NEJM-published study
2M ago
3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 3/31/2025, According to Top Analysts
2M ago
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
Premium
The Fly
Mineralys Therapeutics presents results from Phase 2 Advance-HTN trial
2M ago
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
Premium
Ratings
Promising Clinical Trial Results and Safety Profile of Lorundrostat Support Buy Rating for Mineralys Therapeutics
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100